Skip to content

Bolus Dosing of Remifentanil with Propofol for Gynaecological Day Case Surgery

Bolus Dosing of Remifentanil with Propofol for Gynaecological Day Case Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN27187868
Enrollment
Unknown
Registered
2004-09-30
Start date
2003-10-24
Completion date
Unknown
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Anaesthesia Surgery

Interventions

To study 60 American Society of Anesthesiologists (ASA) 1 and 2 subjects presenting for routine elective minor gynaecological day case surgery. Subjects will be randomised to two groups A and B.

Sponsors

Department of Health
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ASA 1 and 2 subjects presenting for routine elective minor gynaecological day case surgery. All patients attending for surgery will be given a patient information leaflet and those agreeing to participate in the study will be asked to sign a consent form. They will be the subject of therapeutic research.

Exclusion criteria

Exclusion criteria: Patients giving history of reflux or hiatus hernia, obesity or cases requiring tracheal intubation for any other reason.

Design outcomes

Primary

MeasureTime frame
1. Time from end of procedure to 1.1. eyes open 1.2. recollection of name 1.3. fitness to discharge from recovery 1.4. ready for home discharge 2. post-operative pain 3. analgesic requirements 4. nausea and vomiting 5. total dose of agents used

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026